GlassScriptPhysician profile
Babak Edraki
NPI 1942249388
$33,556.74
in general payments reported to CMS, 2019-2025
21 companies · $1,041 in 2025
The $1,041 reported for 2025 was more than what 84% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22K · 2020: $2,734 · 2021: $3,097 · 2022: $3,725 · 2023: $127 · 2024: $461 · 2025: $1,041.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $879 · Education: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $878.63 |
| Education | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $27,579.61 | 2019-2025 | Lynparza |
| Intuitive Surgical, INC. | $2,320.81 | 2021-2025 | |
| Abbvie INC. | $1,722.21 | 2019-2020 | |
| Momentis Surgical INC. | $789.00 | 2022 | |
| Merck Sharp & Dohme LLC | $330.73 | 2019-2025 | Lynparza, Keytruda, Keytruda Qlex |
| Tesaro, INC. | $128.92 | 2019 | |
| Sanara Medtech INC. | $119.31 | 2024 | Celleraterx |
| Avanos Medical | $117.45 | 2019-2025 | On-Q Pump and Accessories |
| Conmed Corporation | $93.55 | 2022-2023 | Airseal |
| Ethicon US, LLC | $62.72 | 2019-2021 | |
| Glaxosmithkline, LLC. | $59.78 | 2020-2025 | Zejula, Jemperli |
| Clovis Oncology, INC. | $58.37 | 2019-2021 | |
| Stryker Corporation | $35.90 | 2019 | |
| Baxter Healthcare | $33.54 | 2021 | |
| Mimedx Group, INC. | $24.58 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $24.53 | 2024 | Entre Plus, Flexitouch Plus |
| Seagen INC. | $22.47 | 2023 | Tivdak |
| Baudax Bio INC. | $20.81 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.45 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Babak Edraki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.